1. Home
  2. COEP vs DALN Comparison

COEP vs DALN Comparison

Compare COEP & DALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • DALN
  • Stock Information
  • Founded
  • COEP 2017
  • DALN 1954
  • Country
  • COEP United States
  • DALN United States
  • Employees
  • COEP 7
  • DALN N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • DALN Newspapers/Magazines
  • Sector
  • COEP Health Care
  • DALN Consumer Discretionary
  • Exchange
  • COEP Nasdaq
  • DALN Nasdaq
  • Market Cap
  • COEP 22.3M
  • DALN 24.6M
  • IPO Year
  • COEP N/A
  • DALN 2008
  • Fundamental
  • Price
  • COEP $9.27
  • DALN $6.79
  • Analyst Decision
  • COEP
  • DALN
  • Analyst Count
  • COEP 0
  • DALN 0
  • Target Price
  • COEP N/A
  • DALN N/A
  • AVG Volume (30 Days)
  • COEP 1.0M
  • DALN 54.4K
  • Earning Date
  • COEP 11-13-2024
  • DALN 03-05-2025
  • Dividend Yield
  • COEP N/A
  • DALN 2.36%
  • EPS Growth
  • COEP N/A
  • DALN N/A
  • EPS
  • COEP N/A
  • DALN N/A
  • Revenue
  • COEP N/A
  • DALN $128,286,000.00
  • Revenue This Year
  • COEP N/A
  • DALN N/A
  • Revenue Next Year
  • COEP N/A
  • DALN N/A
  • P/E Ratio
  • COEP N/A
  • DALN N/A
  • Revenue Growth
  • COEP N/A
  • DALN N/A
  • 52 Week Low
  • COEP $2.31
  • DALN $2.98
  • 52 Week High
  • COEP $13.58
  • DALN $7.86
  • Technical
  • Relative Strength Index (RSI)
  • COEP 75.88
  • DALN 54.49
  • Support Level
  • COEP $6.22
  • DALN $6.75
  • Resistance Level
  • COEP $10.00
  • DALN $7.19
  • Average True Range (ATR)
  • COEP 1.79
  • DALN 0.34
  • MACD
  • COEP 0.43
  • DALN -0.09
  • Stochastic Oscillator
  • COEP 90.51
  • DALN 8.41

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About DALN DallasNews Corporation Series A

DallasNews Corp is a local news and information publishing company in Texas with commercial printing, distribution, and direct mail capabilities, as well as a presence in emerging media and digital marketing.

Share on Social Networks: